|Número de publicación||US3688763 A|
|Tipo de publicación||Concesión|
|Fecha de publicación||5 Sep 1972|
|Fecha de presentación||15 Jul 1970|
|Fecha de prioridad||28 Jul 1969|
|Número de publicación||US 3688763 A, US 3688763A, US-A-3688763, US3688763 A, US3688763A|
|Cesionario original||Cromarty Raymond|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (9), Citada por (32), Clasificaciones (11)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
O United States Patent 51 3,688,763
Cromarty Sept. 5, 1972  DIAGNOSTIC DEVICE AND METHOD 2,798,024 7/1957 Zapapas et al ..424/21 In entor: C marty Parmalea I Enz et a1 Crescent Weston Ontario Canada 3,315,660 4/1967 Abella ..128/2 F I 3,118,439 1/ 1964 Perrenoud 128/2 F  Filed: July 15, 1970 1,438,064 12/1922 Simmons ..128/260 471,343 3/1892 Poehl ..128/260 X  APPL R24,666 7/1959 Draghi ..12s/2 w 298,720 5/1884 Anderson ..128/269 X  Foreign Application Priority Data Primary Examinerl(yle L. Howell July 28, 1969 Great Britain ..37,84l/69 Att0mey Maybee & Legris  US. Cl. .JZB/Z B, 128/2 F, l28/2 W 57 ABSTRACT  Int. Cl. ..A6lb 10/00  Field of Search 128/2 w 2 B, 2 F 2 p 2 R, Cellular material 18 collected from the large intestine 2 72 213 2 0 2 1 2 9. 424/ 9 22 Of a patient on a sponge. Tl'1 patient swallows the sponge contained compressed in a gelatin casing with  References Ciud an enteric coating, the casing being dissolved in the large intestine to release the sponge, which is naturally UNITED STATES PATENTS evacuated by the patient and recovered for analysis.
1,575,123 3/ 1926 Martocci-Pisculli...128l285 X 4 Claims, 1 Drawing Figure PATENTEDSEP 51912 3688.763
l NW-"EN'H R RAYMOND CROMARTY Attorneys DIAGNOSTIC DEVICE AND METHOD BACKGROUND OF THE INVENTION This invention relates to a diagnostic method for the detection of diseases and to a diagnostic device. More particularly, it relates to a method of and device for obtaining cellular material from the large intestine of a patient, for subsequent cytological examination.
BRIEF DESCRIPTION OF THE PRIOR ART It has previously been proposed to collect cells from the large intestine of a patient, for subsequent analysis, by injecting the patient anally with a polymerizable liquid composition. The composition polymerizes in situ in the body cavity to form a cellular, sponge-like mass, upon which cells from the body cavity deposit. The sponge-like mass is evacuated by the normal defecatory process of the patient, recovered, and the cells deposited thereon, removed and analyzed.
Such a procedure has the disadvantage that it requires expensive composition and equipment, and has to be carried out by skilled, medically trained personnel. It cannot be conducted by the patient himself, away from medical facilities.
SUMMARY OF THE INVENTION An object of the present invention is to provide a novel method of collecting cellular material from the large intestine of a patient, and a device therefor.
A further object is to provide a simple such method which can be conducted by the patient himself, and involves the use of an inexpensive device only.
According to one aspect of the present invention, there is provided a method of collecting cellular material from the large intestine of a patient, which comprises administering orally to the patient a capsule comprising a readily compressible sponge of fine pore structure enclosed in a gelatin or similar enzymedegradable casing, the casing having an enteric coating over its outer surface, recoveringthe sponge after its natural evacuation from the body, and recovering from the sponge cells collected thereon during its passage through the large intestine of the body.
According to a second aspect of the invention, there is provided a diagnostic device of an overall size such as to allow it to be swallowed by a patient and passed through the intestines of the body, said device comprising a sponge retained in compressed form inside a capsule, the capsule being insoluble in gastric juices of the stomach, but soluble to release the sponge in the large intestine.
BRIEF DESCRIPTION OF THE DRAWING The accompanying drawing shows an exploded view of a preferred embodiment of a diagnostic device according to the present invention.
The device is in the form of a capsule having two interfitting half shells l and 11, of circular cross section, of gelatin. Inside the shells of gelatin is provided a sponge 12. The sponge is compressed inside the shells, from a relaxed diameter of about 1 inch, to a diameter of about one-fourth inch, which is the approximate inner diameter of the gelatin shells.
After insertion of the sponge 12, the interfitting of the two half shells l0 and 11 to make a capsule, the
capsule is provided with an overall exterior enteric coating 13, which seals the capsule. The capsule is then ready to be administered to the patient. lts overall size is suitably three-fourths inch in length and one-fourth inch in diameter.
DESCRIPTION OF PREFERRED EMBODIMENTS The type of sponge is chosen with a view to easy compressibility, and very small adherence in relation to the walls of the intestines of the body. It must also, of course, be inert to the action of fluids present in the intestines, to which it will be exposed during use. Finely porous polyurethane sponge is suitable.
Suitable enteric coatings are those based on cellulose acetate phthalate. The coating may be applied in solvent form, for example as a solution in methylene chloride. The coating may also include additional ingredients such as plasticizers, e.g. ethyl phthalate, and non-friction aids, such as silicones.
In use, the capsule is swallowed by the patient, and passes into the stomach. Due to the presence of the enteric coating, the capsule remains unchanged and unaffected in the stomach, and passes into the small intestine. The secretions present in the small intestine start to attack the enteric coating and dissolve it. The gelatin shells are then attached by these secretions. Thus the capsule is disintegrated and the sponge released in the small intestine. The sponge is propelled along the intestines by the normal peristaltic action of the intestines, and eventually enters the large intestine. Here, the re-expanded sponge absorbs mucous, containing cells from the large intestine. The sponge travels on as before and is eventually naturally expelled from the anus, where it is carefully collected and the cells it has picked up removed and analyzed.
Preferably, the capsule is administered to the patient after a laxative, to clear the intestines of fecal material, and after several hours have elapsed since the patient consumed food. Further food should not be taken by the patient within about 7 hours after swallowing the capsule. This is to ensure that the sponge, when recovered,-is not contaminated with excessive amounts of fecal material, hindering analysis of the cells it has collected. The time from swallowing to emission of the sponge in the process of the present invention is normally about 12 hours.
By means of this invention, the presence of malignant cells in the large intestines can be determined, allowing early detection of pathological process of this organ.
What I claim as my invention is:
l. A method of collecting cellular material from the large intestine of a patient, which comprises fasting the patient, administering orally to the patient a capsule comprising an enzyme degradable casing, an enteric coating over the outer surface of said casing, and a readily compressible sponge of fine pore structure enclosed within said casing, recovering the sponge material after its natural evacuation from the body, and recovering from the sponge cells collected thereon during its passage through the large intestine of the body.
2. The method of claim 1 wherein the sponge is finely porous polyurethane sponge, and the casing is of gelatine.
4. A diagnostic device of an overall size such as to allow it to be swallowed by a patient and passed through the intestines of the body, said device being generally cylindrical in overall shape and comprising an enzyme degradable gelatine casing, a cellulose acetate phthalate based enteric coating over the outer surface of said casing, and a readily compressible and re-expandable finely porous polyurethane sponge retained and enclosed within said casing in a compressed form.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US24666 *||5 Jul 1859||Improvement in revolving fire-arms|
|US298720 *||14 Feb 1884||20 May 1884||Capsule|
|US471343 *||30 Sep 1889||22 Mar 1892||Alexander poehl|
|US1438064 *||16 Nov 1921||5 Dic 1922||Johnson & Johnson||Dental pellet|
|US1575123 *||1 Ago 1922||2 Mar 1926||Leon Martocci-Pisculli||Medical appliance|
|US2798024 *||2 Jun 1954||2 Jul 1957||Lilly Co Eli||Composite enteric tablet of erythromycin and sulfonamides|
|US3081233 *||8 Ago 1960||12 Mar 1963||Upjohn Co||Enteric-coated pilules|
|US3118439 *||19 Mar 1958||21 Ene 1964||Jean-Pierre Perrenoud||Diagnostic and medicating capsule and the method of use|
|US3315660 *||8 Ago 1963||25 Abr 1967||Abella Carlos A||Capsule for insertion in the digestive track|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3877464 *||17 Ago 1973||15 Abr 1975||Vermes Andrew R||Intra-uterine biopsy apparatus|
|US3998211 *||20 Dic 1974||21 Dic 1976||Louis Bucalo||Structures for growing cultures within human and animal bodies|
|US4172446 *||30 Dic 1975||30 Oct 1979||Louis Bucalo||Apparatus for collecting body fluids|
|US4186730 *||2 Dic 1976||5 Feb 1980||Louis Bucalo||Methods for collecting body fluids|
|US4257427 *||13 Sep 1979||24 Mar 1981||Louis Bucalo||Method for collecting body fluids|
|US4735214 *||5 Sep 1986||5 Abr 1988||Berman Irwin R||Gastrointestinal diagnostic capsule and method of use|
|US4774962 *||23 Sep 1986||4 Oct 1988||Walter Sarstedt Kunststoff-Spritzgusswerk||Method of extracting human saliva|
|US4817632 *||23 Jun 1987||4 Abr 1989||Bioquant, Inc.||Oral fluid collection article|
|US4979947 *||10 Oct 1985||25 Dic 1990||Berman Irwin R||Encapsulated expandible continence device|
|US5113871 *||8 Jul 1988||19 May 1992||Jouko Viljanto||Device for the determination of incisional wound healing ability|
|US5231992 *||10 Dic 1991||3 Ago 1993||Leon Arnaldo C||Low-impact cervical cell and fluid collector|
|US5576020 *||14 Abr 1995||19 Nov 1996||Kanegafuchi Kagaku Kogyo Kabushiki Kaisha||Adjuvant for pharmaceutical preparations|
|US5603950 *||7 Nov 1994||18 Feb 1997||Ratjen; Werner||Agent for oral intake|
|US5644012 *||16 Nov 1992||1 Jul 1997||Kanegafuchi Kagaku Kogyo Kabushiki Kaisha||Adjuvant for pharmaceutical preparations|
|US5854368 *||30 Dic 1996||29 Dic 1998||Kanegafuchi Kagaku Kogyo Kabushiki Kaisha||Adjuvant for pharmaceutical preparations|
|US5971942 *||3 Dic 1996||26 Oct 1999||Gu; Howard H.||Intestinal fluid sampler|
|US8491495 *||30 Nov 2012||23 Jul 2013||L. Zane Shuck||Human intestinal tract research and diagnostic system to evaluate patients and advance medical science and bioengineering and to determine processes in the gut and causes of diseases|
|US8915863 *||28 Jun 2013||23 Dic 2014||L. Zane Shuck||In vivo device and method for researching GI tract processes, microbes, and variables associated with illnesses and diseases|
|US8926526 *||28 Jun 2013||6 Ene 2015||L. Zane Shuck||Patient in vivo gut diagnostic and treatment tool|
|US9215997 *||28 Jun 2013||22 Dic 2015||L. Zane Shuck||In vivo technology system for human gut research, diagnostics and treatment|
|US20030072804 *||26 Feb 2002||17 Abr 2003||The Procter & Gamble Company||Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body|
|US20030091610 *||20 Sep 2002||15 May 2003||The Procter & Gamble Company||Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body|
|US20040022972 *||20 Jul 2001||5 Feb 2004||Machines Industrielles Etablissements||Consumable container|
|US20100291266 *||15 May 2009||18 Nov 2010||Tibor Czinki||Natural Sponge Food and Regimen|
|US20140162305 *||28 Jun 2013||12 Jun 2014||L. Zane Shuck||Patient In Vivo Gut Diagnostic and Treatment Tool|
|US20140163416 *||28 Jun 2013||12 Jun 2014||L. Zane Shuck||In Vivo Device and Method for Researching GI Tract Processes, Microbes, and Variables Associated with Illnesses and Diseases|
|US20150112166 *||28 Jun 2013||23 Abr 2015||L. Zane Shuck||In Vivo Technology System for Human Gut Research, Diagnostics and Treatment|
|EP0542299A2 *||13 Nov 1992||19 May 1993||Kanegafuchi Kagaku Kogyo Kabushiki Kaisha||Ester linkage containing polymers for use in pharmaceutical preparations|
|WO1989000403A1 *||8 Jul 1988||26 Ene 1989||Huhtamaeki Oy||Device and method for the determination of incisional wound healing ability|
|WO2001017509A1 *||5 Sep 2000||15 Mar 2001||Beisel Guenther||Method for improving and maintaining bowel function as well as a method for the production thereof|
|WO2001017510A1 *||5 Sep 2000||15 Mar 2001||Guenther Beisel||Agent for stimulating bowel function and method for producing the same|
|WO2002015887A1 *||20 Jul 2001||28 Feb 2002||Mach Ind Etablissements||Consumable container|
|Clasificación de EE.UU.||600/572, 600/582|
|Clasificación internacional||A61B10/00, A61B10/02, A61K9/48|
|Clasificación cooperativa||A61B10/02, A61K9/4891, A61K9/4866|
|Clasificación europea||A61K9/48H6, A61B10/02, A61K9/48Z|